Frequently Asked Questions
CARVIOVASCULAR AND LYMPHATIC SYSTEMS & WOBENZYM®
What heart conditions has Wobenzym®
been used on?
When Wobenzym® was added to the
treatment of
angina pectoris (chest pain due to
heart problems), the frequency and intensity of angina attacks were
reduced and tolerance to physical load was increased. A drop in
pro-inflammatory cytokine levels was also noted.
Patients who have suffered a myocardial infarction – a heart attack
– had lower risk of re-infarction when they were given Wobenzym®.
Normalization of lymphocytes, and a lowering of circulating immune
complexes was observed.
Wobenzym® also decreased cholesterol an average of 24%
after one month of therapy. It also lowered the levels of
atherogenic lipoproteins as well as inflammatory markers associated
with
atherosclerosis.
It is important to note that in addition to lowering excessive
lipids, controlling inflammation in cardiovascular disease is also
recognized as an important benefit of systemic enzyme support.
In
addition to controlling the inflammation that causes heart disease,
can Wobenzym® lower cholesterol?
One study showed that in patients who had suffered a
myocardial infarction, cholesterol dropped
12% and lipoproteins drops 16% after taking 9 Wobenzym®
tablets a day for 10 days. A second group in the same study had a
24% drop of cholesterol and 31% drop of lipoproteins within one
month at the same dosage. The researched also noted that the immune
status of myocardial infarction (MI) patients is significantly
impaired and that Wobenzym® had an immunonormalizing
affect.
A parallel study of myocardial infarction patients and two groups of
rabbits reported a “significant decrease of cholesterol level” in
both the clinical and the experimental studies. They concluded that
“it can be recommended to use Wobenzym in complex treatment of
myocardial infarction patients to reduce risk factors of
reinfarction.”
A 2001 study tracked 52 patients taking Wobenzym® for 6
months. They also noted an improvement lipid levels. They also noted
an improvement in cytokine levels, and concluded in postmyocardial
infarction patients Wobenzym® helped improve the
biochemical and immune abnormalities.
It is also notable that patients with autoimmune thyroid disease
experienced lower cholesterol and triglyceride levels after being
treated with Wobenzym®. Now this may be because their
anti-thyroid antibody levels had dropped with Wobenzym®
therapy, but it is still notable that cholesterol levels are
improved in these patients.
I should also point out that improved cholesterol levels are also
observed in chronic levier disease patients after they were treated
with Wobenzym®
Can
Wobenzym be taken if people are on other medication for their heart
disease?
The studies are telling use yes. In some studies, the
patients were also on beta-blockers, nitrates, aspirin and
inhibitors ACE. Learn more at:
Myocardial Infarction
I should point out that since Wobenzym has a fibrinolytic action –
it decreased blot clots – patients taking powerful anticoagulants
such a warfarin (trade name Coumadin) or other prescription blood
thinners, should not take Wobenzym, unless under the supervision of
a physician that is experienced in systemic enzyme therapy and
coagulation management. Study report it is safe to take with
aspirin.
How
does Wobenzym help other parts of the circulatory system, such as
the veins?
A common disease that affects veins is
thrombophlebitis – which is an inflammation of the veins due to
blood clotting. A number of studies show that Wobenzym®
is very effective in decreasing the pain,
edema and throphic ulcers often seen in thrombophlebitis and post-thrombophlebitis
syndrome. The studies show improvement of blood flow with increased
blood fibrinolytic activity and inhibited platelet function.
In a randomized double blind phase III clinical trial they
noted that after 15 days of treatment, there was a significant
difference in favor of the enzyme treatment when pain, redness,
swelling and induration ( a hardening of the tissue due to swelling
and inflammation). We see the same improvement in lymphedema.
How is lymphedema related to the circulatory
system, and how does Wobenzym® improve this condition?
Lymph is the fluid that is formed from the fluids
that bathe and surround the cells in the tissues of the body. This
fluid is carried back to the circulation through lymphatic vessels.
When these vessels do not drain properly the fluid collects in the
tissues causing edema, or more specifically
lymphedema.
So, lymphedema is the swelling of tissue due to retention of fluid
in the lymph vessels. Lymphedema can have many causes affects 175
million people worldwide, and can lead to infection, pain, severe
disability and even increased risk of cancer. It is a disorder which
is traditionally very difficult to treat. So you can realize why I
was pleased to read the studies that were done with Wobenzym®
treating lymphedema.
What I found, was that a number of studies specifically looked at
the affect that Wobenzym® has on lymphedema. It was noted
that there was significant reduction in pain and swelling with a
lower risk of infections. Even primary lymphedema (hereditary
lymphedema) showed significant improvement.
Back
to Frequently Asked Questions